Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 188

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses

Open access
Ladner, Jason T., Henson, Sierra N., Boyle, Annalee S., Engelbrektson, Anna L., Fink, Zane W., Rahee, Fatima, D’ambrozio, Jonathan, Schaecher, Kurt E., Stone, Mars, Dong, Wenjuan, Dadwal, Sanjeet, Yu, Jianhua, Caligiuri, Michael A., Cieplak, Piotr, Bjørås, Magnar, Fenstad, Mona H., Nordbø, Svein A., Kainov, Denis E., Muranaka, Norihito, Chee, Mark S., Shiryaev, Sergey A., Altin, John A.·2021·Cell Reports Medicine

Abstract

A high-resolution understanding of the antibody response to SARS-CoV-2 is important for the design of effective diagnostics, vaccines and therapeutics. However, SARS-CoV-2 antibody epitopes remain largely uncharacterized, and it is unknown whether and how the response may cross-react with related viruses. Here, we use a multiplexed peptide assay ('PepSeq') to generate an epitope-resolved view of reactivity across all human coronaviruses. PepSeq accurately detects SARS-CoV-2 exposure and resolves epitopes across the Spike and Nucleocapsid proteins. Two of these represent recurrent reactivities to conserved, functionally-important sites in the Spike S2 subunit, regions that we show are also targeted for the endemic coronaviruses in pre-pandemic controls. At one of these sites, we demonstrate that the SARS-CoV-2 response strongly and recurrently cross-reacts with the endemic virus hCoV-OC43. Our analyses reveal new diagnostic and therapeutic targets, including a site at which SARS-CoV-2 may recruit common pre-existing antibodies and with the potential for broadly-neutralizing responses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.xcrm.2020.100189

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 188

Metadata

Authors
Ladner, J. T., Henson, S. N., Boyle, A. S., Engelbrektson, A. L., Fink, Z. W., Rahee, F., D’ambrozio, J., Schaecher, K. E., Stone, M., Dong, W., Dadwal, S., Yu, J., Caligiuri, M. A., Cieplak, P., Bjørås, M., Fenstad, M. H., Nordbø, S. A., Kainov, D. E., Muranaka, N., Chee, M. S., Shiryaev, S. A., & Altin, J. A.
Venue
Cell Reports Medicine
Publisher
Elsevier BV
Published
2021-01
Volume
2
Issue
1
Pages
100189
ISSN
2666-3791 (ISSN-L)
OpenAlex
W3124415907
Cited by
188
References
7
FWCI
12.14
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses. https://app.cochat.ai/papers/10.1016/j.xcrm.2020.100189
The paper
Ladner, J. T., Henson, S. N., Boyle, A. S., Engelbrektson, A. L., Fink, Z. W., Rahee, F., D’ambrozio, J., Schaecher, K. E., Stone, M., Dong, W., Dadwal, S., Yu, J., Caligiuri, M. A., Cieplak, P., Bjørås, M., Fenstad, M. H., Nordbø, S. A., Kainov, D. E., Muranaka, N., . . . Altin, J. A. (2021). Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2020.100189

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.